Skip to content

Effects of an Oral Herbal Supplement on Skin Aging, Hydration, and Elasticity

Prospective, Double-Blinded, Randomized Placebo Controlled Study of an Oral Herbal Supplement on Photoaged Skin and Elasticity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06146140
Enrollment
36
Registered
2023-11-24
Start date
2023-12-01
Completion date
2024-12-01
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Photoaging

Brief summary

The purpose of this study is to evaluate how an oral herbal supplementation influences facial skin elasticity and facial hydration as well as markers of photoaging (erythema and pigmentation).

Detailed description

Skin is the largest organ of the body and skin aging represents a primary indicator of the aging process in the body. Photoaging is among the most crucial factors that cause skin aging damage. Photoaged skin is primarily induced by prolonged exposure to ultraviolet radiation leading to the appearance of increased skin pigmentation, reduced elasticity, and pronounced wrinkles. There has been an increasing recognition of the influence of nutrition on skin health with dietary elements emerging as a viable alternative approach to preventing photoaging. The aim of this study is to understand how oral supplementation impacts photoaged skin, facial hydration, and facial elasticity.

Interventions

DIETARY_SUPPLEMENTOral herbal supplement

Take one capsule daily

DIETARY_SUPPLEMENTOral placebo supplement

Take one capsule daily

Sponsors

Vidya Herbs
CollaboratorUNKNOWN
Integrative Skin Science and Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

\- Women who are 35 to 55 years of age

Exclusion criteria

* Individuals who are pregnant or breastfeeding. * Prisoners. * Adults unable to consent. * Those who are unwilling to discontinue topical probiotics, topical hydroquinone, retinoids, bakuchiol, vitamin C, or acetyl zingerone containing products for two weeks to meet the washout criteria prior to enrolling. * Subjects with any of the following facial cosmetic treatments in the past 3 months or those who are unwilling to withhold the following facial cosmetic treatments during the study including botulinum toxin, injectable fillers, microdermabrasion, intense pulsed light (IPL), peels, laser treatments, acid treatments, facial plastic surgery, or any other medical treatment administered by a physician or skin care professional which is designed to improve the appearance of facial skin. * Individuals who have changed any of their hormonal based contraception within 3 months prior to joining the study. * Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years. * Any known allergy to any of the ingredients in the study product. * Those who have been on an oral antibiotic within 1 month prior enrolling * Those who are unwilling to discontinue oral probiotics-based supplementation or supplement ingredients found in the study's oral, product 1 month prior to enrollment

Design outcomes

Primary

MeasureTime frameDescription
Change in Skin Elasticity8 weeksSkin elasticity measured with a handheld non-invasive device (Cutometer, Delfin Technologies Ltd.)
Change in Skin Hydration8 weeksThe skin capacitance will be measured with a handheld non-invasive device (Skin MoistureMeterSC, Delfin Technologies Ltd.). The measurement is in arbitrary units per manufacturer.

Secondary

MeasureTime frameDescription
Change in the skin erythema8 weeksFacial photographs will be obtained and analyzed utilizing the BTBP 3D Clarity Pro Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA, USA). The measurement will analyze erythema intensity and will be reported as a relative change from baseline.
Change in skin transepidermal water loss8 weeksSkin transepidermal water loss measured with a handheld non-invasive device (Vapometer, Delfin Technologies Ltd.)
Change in skin pigmentation intensity8 weeksFacial photographs will be obtained and analyzed utilizing the BTBP 3D Clarity Pro Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA, USA). The measurement will analyze pigment intensity and will be reported as a relative change from baseline.
Product Tolerability8 weeksAssessed with the use of a tolerability questionnaire to be completed by participants. Tolerability will be measured by rating symptoms such as burning, stinging, and scaling.
Self-perception of skin (changes in facial fine lines and wrinkles, firmness, etc)8 weeksAssessed with the use of a subjective questionnaire to be completed by participants. Self-perception will be measured by rating symptoms of skin improvement, clarity, smoothness, etc.)
Change in appearance of facial wrinkles8 weeksFacial photographs will be obtained and analyzed utilizing the BTBP 3D Clarity Pro Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA, USA). The measurement will analyze wrinkle severity that is a measure of both the wrinkle depth and width and will be reported as a relative change from baseline.

Contacts

Primary ContactLaila Afzal
laila@integrativeskinresearch.com916-524-1216
Backup ContactNasima Afzal
nasima@integrativeskinresearchc.om916-524-1216

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026